NCT01597557View on ClinicalTrials.gov

Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial

NACompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Atrial Fibrillation
Interventions
DRUG

Magnesium Sulfate

2 grams intravenous drip over 30 minutes

OTHER

Placebo

Normal Saline 50 ml intravenous drip over 30 minutes

Trial Locations (1)

14214

State University of New York at Buffalo, Buffalo

All Listed Sponsors
lead

State University of New York at Buffalo

OTHER

NCT01597557 - Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial | Biotech Hunter | Biotech Hunter